SS
State Street Corp cut its ACAD stake below 5%
State Street Corp reported owning 4.4% of Acadia Pharmaceuticals Inc (ACAD) (7,650,889 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 10, 2026
- Source
- Schedule 13G